FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Wednesday

 

Relationship Between Timed 25-Foot Walk Impairment and Diffusion Tensor Imaging Markers in Multiple Sclerosis: STUDY




























Image source: http://article.wn.com/





ABSTRACT

Objective:
To identify relationships between Timed 25-foot walk (T25FW) and both conventional MRI and diffusion tensor imaging (DTI) in MS patients.

Background:
T25FW is commonly used to gauge gait impairment in MS. We have previously shown widely variable response to Ampyra (dalfampridine) using this measure. Objective biological markers that correlate with patients’ disability are needed. DTI, quantifying fiber tract integrity, might provide such information. To undergird our ongoing investigation into imaging predictors of Ampyra response, we analyzed relationships between T25FW and DTI calculations.

Design/Methods:
Using our previously established cohort of Ampyra-treated subjects with T25FW data, a subset met inclusion criteria for the imaging sub-study. Patients underwent 3T brain and cervical MRI. Conventional metrics included T2 and T1 lesion volume; grey-, white- and normalized brain volume, and cervical cord volume at C2/3. Using restricted FOV (rFOV) RESOLVE DTI, mean diffusivity (MD) and fractional anisotropy (FA) were measured in brain cortico-spinal tracts (CST) and rFOV at C2/3. Hypothesizing that the region of greatest impairment drives loss of function, we analyzed both mean right/left brain CST FA values, as well as the lower of the two values.

Results:
Eleven subjects met inclusion criteria. Mean T25FW was 8.2 seconds (range=4.8-12.5); 73[percnt] patients had progressive disease. Mean brain CST FA was 0.53 (SD=0.038), mean CST MD was 0.8x10-3 mm2/sec (SD=0.06). Mean spinal FA was 0.68 (SD=0.04), and mean MD was 1.08x10-3mm2/sec (SD=0.087). Only lowest CST FA (mean=0.54, SD=0.042) significantly inversely correlated with T25FW (r=-0.63), with a trend using linear regression (p=0.174).

Conclusions:
Our results suggest modest correlation between CST damage shown by FA with T25FW impairment in this Ampyra-treated cohort. Inability to demonstrate cord imaging predictors may relate to known technical limitations of spinal DTI or small sample size. These results will inform our subsequent analyses of MRI predictors of Ampyra response.

Story Source: The above story is based on materials provided by NEUROLOGY
Note: Materials may be edited for content and length

Labels: , ,



Go to Newer News Go to Older News